Drug repurposing screens identify chemical entities for the development of COVID-19 interventions

Here, the authors perform repurposing screens of the ReFRAME drug library in two cell lines and identify inhibitors of SARS-CoV-2 infection. Antiviral activity of prodrug MK-4482 is confirmed in hamsters.

Guardado en:
Detalles Bibliográficos
Autores principales: Malina A. Bakowski, Nathan Beutler, Karen C. Wolff, Melanie G. Kirkpatrick, Emily Chen, Tu-Trinh H. Nguyen, Laura Riva, Namir Shaabani, Mara Parren, James Ricketts, Anil K. Gupta, Kastin Pan, Peiting Kuo, MacKenzie Fuller, Elijah Garcia, John R. Teijaro, Linlin Yang, Debashis Sahoo, Victor Chi, Edward Huang, Natalia Vargas, Amanda J. Roberts, Soumita Das, Pradipta Ghosh, Ashley K. Woods, Sean B. Joseph, Mitchell V. Hull, Peter G. Schultz, Dennis R. Burton, Arnab K. Chatterjee, Case W. McNamara, Thomas F. Rogers
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/b79629899ac84da0ab6e053c69619b49
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b79629899ac84da0ab6e053c69619b49
record_format dspace
spelling oai:doaj.org-article:b79629899ac84da0ab6e053c69619b492021-12-02T17:51:27ZDrug repurposing screens identify chemical entities for the development of COVID-19 interventions10.1038/s41467-021-23328-02041-1723https://doaj.org/article/b79629899ac84da0ab6e053c69619b492021-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23328-0https://doaj.org/toc/2041-1723Here, the authors perform repurposing screens of the ReFRAME drug library in two cell lines and identify inhibitors of SARS-CoV-2 infection. Antiviral activity of prodrug MK-4482 is confirmed in hamsters.Malina A. BakowskiNathan BeutlerKaren C. WolffMelanie G. KirkpatrickEmily ChenTu-Trinh H. NguyenLaura RivaNamir ShaabaniMara ParrenJames RickettsAnil K. GuptaKastin PanPeiting KuoMacKenzie FullerElijah GarciaJohn R. TeijaroLinlin YangDebashis SahooVictor ChiEdward HuangNatalia VargasAmanda J. RobertsSoumita DasPradipta GhoshAshley K. WoodsSean B. JosephMitchell V. HullPeter G. SchultzDennis R. BurtonArnab K. ChatterjeeCase W. McNamaraThomas F. RogersNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Malina A. Bakowski
Nathan Beutler
Karen C. Wolff
Melanie G. Kirkpatrick
Emily Chen
Tu-Trinh H. Nguyen
Laura Riva
Namir Shaabani
Mara Parren
James Ricketts
Anil K. Gupta
Kastin Pan
Peiting Kuo
MacKenzie Fuller
Elijah Garcia
John R. Teijaro
Linlin Yang
Debashis Sahoo
Victor Chi
Edward Huang
Natalia Vargas
Amanda J. Roberts
Soumita Das
Pradipta Ghosh
Ashley K. Woods
Sean B. Joseph
Mitchell V. Hull
Peter G. Schultz
Dennis R. Burton
Arnab K. Chatterjee
Case W. McNamara
Thomas F. Rogers
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
description Here, the authors perform repurposing screens of the ReFRAME drug library in two cell lines and identify inhibitors of SARS-CoV-2 infection. Antiviral activity of prodrug MK-4482 is confirmed in hamsters.
format article
author Malina A. Bakowski
Nathan Beutler
Karen C. Wolff
Melanie G. Kirkpatrick
Emily Chen
Tu-Trinh H. Nguyen
Laura Riva
Namir Shaabani
Mara Parren
James Ricketts
Anil K. Gupta
Kastin Pan
Peiting Kuo
MacKenzie Fuller
Elijah Garcia
John R. Teijaro
Linlin Yang
Debashis Sahoo
Victor Chi
Edward Huang
Natalia Vargas
Amanda J. Roberts
Soumita Das
Pradipta Ghosh
Ashley K. Woods
Sean B. Joseph
Mitchell V. Hull
Peter G. Schultz
Dennis R. Burton
Arnab K. Chatterjee
Case W. McNamara
Thomas F. Rogers
author_facet Malina A. Bakowski
Nathan Beutler
Karen C. Wolff
Melanie G. Kirkpatrick
Emily Chen
Tu-Trinh H. Nguyen
Laura Riva
Namir Shaabani
Mara Parren
James Ricketts
Anil K. Gupta
Kastin Pan
Peiting Kuo
MacKenzie Fuller
Elijah Garcia
John R. Teijaro
Linlin Yang
Debashis Sahoo
Victor Chi
Edward Huang
Natalia Vargas
Amanda J. Roberts
Soumita Das
Pradipta Ghosh
Ashley K. Woods
Sean B. Joseph
Mitchell V. Hull
Peter G. Schultz
Dennis R. Burton
Arnab K. Chatterjee
Case W. McNamara
Thomas F. Rogers
author_sort Malina A. Bakowski
title Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
title_short Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
title_full Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
title_fullStr Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
title_full_unstemmed Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
title_sort drug repurposing screens identify chemical entities for the development of covid-19 interventions
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/b79629899ac84da0ab6e053c69619b49
work_keys_str_mv AT malinaabakowski drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT nathanbeutler drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT karencwolff drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT melaniegkirkpatrick drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT emilychen drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT tutrinhhnguyen drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT laurariva drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT namirshaabani drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT maraparren drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT jamesricketts drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT anilkgupta drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT kastinpan drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT peitingkuo drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT mackenziefuller drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT elijahgarcia drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT johnrteijaro drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT linlinyang drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT debashissahoo drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT victorchi drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT edwardhuang drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT nataliavargas drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT amandajroberts drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT soumitadas drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT pradiptaghosh drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT ashleykwoods drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT seanbjoseph drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT mitchellvhull drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT petergschultz drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT dennisrburton drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT arnabkchatterjee drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT casewmcnamara drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
AT thomasfrogers drugrepurposingscreensidentifychemicalentitiesforthedevelopmentofcovid19interventions
_version_ 1718379249691262976